D-1033-2020 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-1033-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Mar 13, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. The recall status is terminated (terminated Feb 9, 2021). Affected quantity: 172,320 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Mar 13, 2020
Termination Date
Feb 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
172,320 bottles

Product description

Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.

Reason for recall

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Distribution pattern

Nationwide in the USA

Code information

Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1033-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1033-2020. Report a data issue: hello@regdatalab.com.